Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...

Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest and technology. Her stories hold a mirror to society, reflecting both its malaise and its beauty.

Find the latest Compass Therapeutics, Inc. (CMPX) stock quote, history, news and other vital information to help you with your stock trading and investing.

The merger of Compass and Anywhere Real Estate would create a company valued at about $10 billion, with a network of roughly 340,000 real estate professionals across 120 countries and territories.